US2005244436A1PendingUtilityA1
Combination Neisserial compositions
Est. expiryMay 19, 2019(expired)· nominal 20-yr term from priority
A61P 31/04A61P 37/04A61K 39/39C07K 14/22A61K 2039/55505A61K 2039/70A61K 2039/53A61K 39/095A61K 39/02A61K 38/164A61K 39/00
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions comprising a first biological molecule from a Neisseria bacterium and a second biological molecule from a Neisseria bacterium. The term “biological molecule” includes proteins and nucleic acids. Preferred Neisseria species are N.meningitidis and N.gonorrhoeae.
Claims
exact text as granted — not AI-modified1 . A composition comprising a first isolated biological molecule from a Neisseria bacterium and a second isolated biological molecule from a Neisseria bacterium, wherein the first biological molecule is from ORF 287 and the second biological molecule is from ORF 961.
2 . The composition of claim 1 , wherein said first biological molecule and said second biological molecule are from the same Neisseria species.
3 . The composition of claim 1 , wherein said first biological molecule and said second biological molecule are from different Neisseria species.
4 . The composition of claim 1 , wherein said first biological molecule and said second biological molecule are from N.meningitidis and/or N.gonorrhoeae
5 . The composition of claim 1 , wherein said first biological molecule and said second biological molecule are from N.meningitidis.
6 . The composition of claim 1 , wherein said first biological molecule comprises an amino acid sequence with at least 65% sequence identity to a contiguous sequence of amino acids selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, and an immunogenic fragment comprising at least 10 contiguous amino acids of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4; and said second biological molecule comprises an amino acid sequence with at least 65% sequence identity to a contiguous sequence of amino acids selected from the group consisting of SEQ ID NO:5, SEQ ID NO:6, and an immunogenic fragment comprising at least 10 contiguous amino acids of SEQ ID NO:5 or SEQ ID NO:6:
7 . The composition of claim 6 , wherein said first biological molecule is selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4.
8 . The composition of claim 7 , wherein said first biological molecule is SEQ ID NO:1.
9 . The composition of claim 6 , wherein said second biological molecule is selected from the group consisting of SEQ ID NO:5, and SEQ ID NO:6.
10 . The composition of claim 9 , wherein said second biological molecule is SEQ ID NO:6.
11 . A composition comprising a first isolated biological molecule from a Neisseria bacterium and a second isolated biological molecule from a Neisseria bacterium, wherein
(a) said first biological molecule comprises an amino acid sequence with at least 65% identity to the contiguous sequence of amino acids of SEQ ID NO:1 or an immunogenic fragment comprising at least 10 contiguous amino acids of SEQ ID NO:1; and (b) said second biological molecule comprises an amino acid sequence with at least 65% identity to the contiguous sequence of amino acids of SEQ ID NO:6 or an immunogenic fragment comprising at least 10 contiguous amino acids of SEQ ID NO:6.
12 . The composition of claim 11 , wherein said first biological molecule comprises the amino acid sequence of SEQ ID NO:1, and said second biological molecule comprises the amino acid sequence of SEQ ID NO:6.
13 . The composition of claim 1 , further comprising an adjuvant.
14 . The composition of claim 12 , further comprising an adjuvant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.